What did @elizajane1983 actually say?
Honestly? Almost nothing factual. The transcript from this 28K-view TikTok is song lyrics, not health commentary. The words captured are something like "I grew good enough" and "damn all of the night" repeated over a beat. This is a transformation video set to music, not a verbal claims video.
The actual information here comes from the caption, not the spoken content. The caption tells us the creator has been on Zepbound for 10 months, identifies as someone with hypothyroidism, and tags the IVIM Health affiliate program. That context matters more than anything said aloud in the clip.
So let's be clear about scope: we're fact-checking what a 10-month Zepbound journey video implies and what the caption signals, because the transcript itself gives us nothing to work with medically.
Does the science back this up?
The implied premise, that tirzepatide (Zepbound) produces meaningful weight loss over 10 months, is well-supported by evidence. But the hypothyroidism angle in the hashtags deserves scrutiny, because it's more complicated than most GLP-1 content acknowledges.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed that tirzepatide at the highest dose produced an average 22.5% body weight reduction over 72 weeks in adults with obesity. Ten months sits inside that window. Those are real, significant numbers.
The hypothyroidism piece is trickier. Levothyroxine absorption can be affected by changes in gut motility, which GLP-1 receptor agonists slow significantly. A 2023 case series in Thyroid journal flagged that some patients on GLP-1 agonists required levothyroxine dose adjustments. Whether the creator experienced this isn't clear, but it's clinically relevant context that most TikTok transformation videos completely skip.
What did they get wrong (or right)?
There's nothing medically wrong said out loud here, because nothing medically specific was said. That's actually a point in this video's favor compared to many GLP-1 creator posts that make explicit dosing claims or promise specific outcomes.
What the video does implicitly suggest, through hashtags and before-and-after framing, is that a 10-month Zepbound run produces dramatic visible results. That implication is broadly consistent with clinical data, though individual results vary significantly. SURMOUNT-1 showed a wide distribution of outcomes, not a uniform 22% loss for every participant.
The IVIM Health affiliate tag is worth flagging. This is a commercial relationship, and viewers deserve to know that. The FTC requires disclosure of material connections in sponsored content. Hashtag disclosure like "#ivimaffiliate" is technically present but easy to miss in a list of 11 other hashtags. That's a gray area that the FTC has pushed back on in enforcement letters.
- No false medical claims made verbally: accurate
- Hypothyroidism complexity not addressed: a gap, not a lie
- Affiliate disclosure present but minimized: borderline compliant
What should you actually know?
If you have hypothyroidism and you're considering a GLP-1 medication like tirzepatide, talk to the clinician managing your thyroid before you start. This is not a scare tactic. Slowed gastric emptying from GLP-1 agonists can change how consistently your levothyroxine absorbs, and an undertreated thyroid can actually make weight loss harder. Your thyroid panel may need monitoring after you start.
Zepbound (tirzepatide) is FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. It is not a lifestyle supplement. It works through dual GIP and GLP-1 receptor agonism, which is a different mechanism than semaglutide-only drugs like Wegovy.
Transformation videos are not clinical data. A single person's 10-month result, however dramatic, tells you nothing reliable about what your body will do. The variance in GLP-1 outcomes is significant, and factors like baseline weight, diet, activity, other medications, and genetics all play a role that no before-and-after photo can capture.